• Soft·Ox Solutions - New ways of eradicating infections and fighting antimicrobial resistance.
  • Patented and clinically proven.
What are you looking for?




SoftOx is a Norwegian MedTech Company

SoftOx Solutions AS (SoftOx, listed at Oslo Stock Exchange Merkur Market) is a Norwegian MedTech company based in Oslo with the aim to contribute to fight major threats to human health, namely:


Emergence of antimicrobial resistance (AMR)

AMR is according to WHO a major threat to global health, with new forms of resistance emerging and can spread with remarkable speed between continents.

Biofilm infections in chronic wounds

There is growing evidence showing the presence of biofilms in non-healing, chronic wounds and their adverse role in wound healing.

Spread of viruses

Deadly viral outbreaks are expected in the future. There is an unmet need for effective and well-tolerated virucidal solutions to aid infection prevention and control.


New ways of eradicating infections

When SoftOx began to work on its formulations 10 years ago, this vision seemed far out of reach. It took belief, hard work, and a bit of luck to successfully get through the uncertainties, setbacks and other challenges, to get to where we are today. Through the dedication and commitment of our team, and the core values we all share, SoftOx is currently in the best position ever. That said, I am equally certain, there will be hurdles on our journey to the top, as we learn to navigate through unprecedented times, as SoftOx matures from its infancy into a well-known brand. It is therefore important to restate that our long-term vision is absolutely on track, and our ongoing research and development activities create more confidence and optimism than ever before.

Charles Alexandre de Calonne once said: “Nothing is impossible, the impossible just takes a little longer” This statement fits well with our dedication to develop solutions serving human health.

Geir Hermod Almås

Chief Executive Officer

Almås, Geir III-min - Statement

Geir Hermod Almås

Chief Executive Officer


Leading Research Institutions & Organizations

After years of research and product development

In collaboration With leading Nordic research institutes

SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully virucidal.

SoftOx is all about Technology

The unique SoftOx technology, developed in close collaboration with expert scientists and clinicians from the the Universities of Skåne and the University of Copenhagen, is based on a combination of naturally occurring chemicals that have been selected by nature to harbour broad antimicrobial effects without inducing resistance. The technology has documented strong antimicrobial effects against all bacteria (including MRSA), fungi and viruses tested. At the same time, the SoftOx technology is very well-tolerated as proven preclinically and clinically. With these favourable benefits / risk profile, the SoftOx technology aims to establish a new standard of disinfectants and wound care products.

Developed With Top Ranked Scientists

Aiming to Solve Major Health Challenges


AntiVir™ - Alcohol-free Hand Disinfection

Inactivating The Corona virus in just 15 seconds

AntiVir™ alcohol-free hand disinfection utilizes the instant microbial killing effect of reactive chemicals selected by nature. The natural ingredients provide a skin friendly and safe hand disinfectant which is clinically proven.

Alcohol-based (70%-85%) hand disinfectants work by interacting with the fatty acid of bacterial cell walls leading to bacterial disruption and death. Since human skin and cells also consists of fat layers, people using alcohol-based hand disinfectantsare at risk to damage their skin, leading to dry and/or eczematous skin. According to WHO, 25-50% of healthcare personnel have skin problems on their hands due to intense hygiene regimens.

In contrast to alcohol, which consists of 75-85 % organic solvent, AntiVir™ is water-based combined with ingredients naturally present in the human body. It does not attack the natural fat layer that protects the skin and is gentle towards the skin’s natural microflora.